These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 38011007)
1. Exploring NK-Cell molecules that impact the immune response and microenvironment in head and neck squamous cell carcinoma. Shao P; Hu WW; Shi XL; Shu MY; Li DY; Zhou T; Zhao QT J Cell Mol Med; 2024 Jan; 28(2):e18045. PubMed ID: 38011007 [TBL] [Abstract][Full Text] [Related]
2. Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584 [TBL] [Abstract][Full Text] [Related]
3. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC. Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648 [TBL] [Abstract][Full Text] [Related]
4. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients. Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X Front Immunol; 2022; 13():1100417. PubMed ID: 36703967 [TBL] [Abstract][Full Text] [Related]
6. Multiomics data analyses to identify SLC25A17 as a novel biomarker to predict the prognosis and immune microenvironment in head and neck squamous cell carcinoma. Shi Y; Huang J; Hu Y; Shen Y BMC Bioinformatics; 2023 Jun; 24(1):269. PubMed ID: 37386359 [TBL] [Abstract][Full Text] [Related]
7. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer. Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791 [No Abstract] [Full Text] [Related]
8. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
9. SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment. Wu Z; You C; Zhu Z; Wu W; Cao J; Xie Q; Deng C; Huang X; Hu S Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):427-440. PubMed ID: 37688682 [TBL] [Abstract][Full Text] [Related]
10. PES1 is a biomarker of head and neck squamous cell carcinoma and is associated with the tumor microenvironment. He Y; Xiang J; Li Y; Huang W; Gu F; Wang Y; Chen R Cancer Med; 2023 Jun; 12(11):12622-12638. PubMed ID: 37076985 [TBL] [Abstract][Full Text] [Related]
11. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients. Li J; Tang LL; Ma J BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785 [TBL] [Abstract][Full Text] [Related]
12. Landscape of natural killer cell activity in head and neck squamous cell carcinoma. Charap AJ; Enokida T; Brody R; Sfakianos J; Miles B; Bhardwaj N; Horowitz A J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33428584 [TBL] [Abstract][Full Text] [Related]
13. CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment. Wu Z; Zhu Z; Wu W; Hu S; Cao J; Huang X; Xie Q; Deng C Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3143-3156. PubMed ID: 38507078 [TBL] [Abstract][Full Text] [Related]
14. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma. Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463 [TBL] [Abstract][Full Text] [Related]
15. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma. Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115 [TBL] [Abstract][Full Text] [Related]
16. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis. Qiang W; Dai Y; Xing X; Sun X Cancer Med; 2022 Aug; 11(16):3168-3181. PubMed ID: 35301800 [TBL] [Abstract][Full Text] [Related]
17. Wei Z; Shen Y; Zhou C; Cao Y; Deng H; Shen Z Bioengineered; 2022 May; 13(5):13784-13800. PubMed ID: 35712757 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma. Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557 [TBL] [Abstract][Full Text] [Related]
19. Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC. Chi H; Xie X; Yan Y; Peng G; Strohmer DF; Lai G; Zhao S; Xia Z; Tian G Front Immunol; 2022; 13():1018685. PubMed ID: 36263048 [TBL] [Abstract][Full Text] [Related]
20. Development and validation of glycosyltransferase related-gene for the diagnosis and prognosis of head and neck squamous cell carcinoma. He M; Wang L; Yue Z; Feng C; Dai G; Jiang J; Huang H; Ji Q; Zhou M; Li D; Chai W Aging (Albany NY); 2024 Jan; 16(2):1750-1766. PubMed ID: 38244579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]